ArticleFrontiers in cardiovascular medicine2026
Sex-based differences in developing heart failure after ST-segment elevation myocardial infarction.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Previous studies have shown that although advances in primary percutaneous coronary intervention (PCI) and medical therapy have significantly improved the survival of patients with ST-segment elevation myocardial infarction (STEMI), the long-term burden of post-infarction heart failure (HF) remains. Studies on sex differences in the occurrence of HF after STEMI are limited. The aim of this study is to investigate the risk factors and gender differences of HF in STEMI patients after PCI. Methods: We conducted a retrospective cohort study, including a total of 1,040 consecutive patients with STEMI. Clinical, laboratory and surgical-related data of the patients were collected. The primary endpoint was the incidence of new-onset HF, and the secondary endpoint was all-cause mortality during the follow-up period. The cumulative event survival rate was estimated using the Kaplan-Meier method. Univariate and multivariate Cox proportional hazards regression analyses were used to determine the independent predictors of HF. Through subgroup and interaction analyses, the consistency of the association between gender and heart failure in different clinical subgroups was evaluated. Results: Compared to men, women were significantly older, had a higher prevalence of diabetes, and experienced longer door-to-balloon times. During follow-up, women exhibited a significantly higher crude incidence of HF (25.88% Conclusion: Women have higher HF morbidity and mortality after STEMI, but this difference is mainly driven by their older age and greater burden of comorbidities, not just biological sex.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.